Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.
Parkinson DR, Abrams JS, Wiernik PH, Rayner AA, Margolin KA, Van Echo DA, Sznol M, Dutcher JP, Aronson FR, Doroshow JH, et al.
Parkinson DR, et al. Among authors: abrams js.
J Clin Oncol. 1990 Oct;8(10):1650-6. doi: 10.1200/JCO.1990.8.10.1650.
J Clin Oncol. 1990.
PMID: 2213101
Clinical Trial.